A Michigan pharmacist sentenced for $4M Medicare fraud highlights ongoing regulatory risks. ACLM promotes lifestyle medicine for chronic disease care. New study finds moderate coffee intake may slow aging in serious mental illness patients.
New Medicare drug price negotiations reduce government costs on 15 high-spend medications, including cancer and diabetes treatments, saving $12 billion annually.
Learn about the 2025 Medicare Open Enrollment Period from October 15 to December 7, including changes to prescription drug coverage and tips for beneficiaries to optimize their health plans.
Explore critical 2025 U.S. healthcare developments affecting insurance markets, from vaccine safety and measles resurgence to drug pricing reforms and medical education loan caps.
Explore UnitedHealthcare’s extensive 2026 policy and program updates for Medicare, Medicaid, and commercial health plans, including coverage expansions, referral changes, and streamlined prior authorizations.
CMS's Medicare Advantage proposal reintroduces the reward factor, affecting insurer payments by $13B, and phases out the inpatient-only list, impacting outpatient care and rural health strategies.
Starting in 2026, Washington state will implement an AI-driven prior authorization pilot for traditional Medicare, raising new compliance and access challenges. Learn about the pilot's impact on Medicare claims processing and healthcare providers.
Medicare's Inflation Reduction Act negotiations cut prices for 15 top prescription drugs by 44%, reducing out-of-pocket costs and impacting Medicare Part D and Part B markets.
CMS announces reduced prices for 15 key Medicare Part D drugs starting in 2027, following the Inflation Reduction Act negotiations, targeting major cost savings in Medicare spending.
Medicare open enrollment from Oct. 15 to Dec. 7 provides beneficiaries a chance to review and adjust their healthcare plans with support from SHINE counselors. Learn how to optimize coverage and manage costs effectively.
